INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 291 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,729 | -18.6% | 390 | 0.0% | 0.01% | -20.0% |
| Q1 2024 | $10,729 | -9.8% | 390 | 0.0% | 0.01% | -9.1% |
| Q4 2023 | $11,892 | -3.6% | 390 | 0.0% | 0.01% | -8.3% |
| Q3 2023 | $12,332 | -22.5% | 390 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $15,905 | +9.4% | 390 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $14,536 | +6.8% | 390 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $13,607 | -38.2% | 390 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $22,000 | +10.0% | 390 | 0.0% | 0.02% | +5.0% |
| Q2 2022 | $20,000 | -28.6% | 390 | 0.0% | 0.02% | -20.0% |
| Q1 2022 | $28,000 | -39.1% | 390 | 0.0% | 0.02% | -39.0% |
| Q4 2021 | $46,000 | -11.5% | 390 | 0.0% | 0.04% | -10.9% |
| Q3 2021 | $52,000 | -17.5% | 390 | 0.0% | 0.05% | -16.4% |
| Q2 2021 | $63,000 | – | 390 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
| Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
| Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
| Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
| Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
| GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
| ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |